Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis

Exclusion Criteria

• •Patients with any clinically significant disease that in the investigator is opinion can´t participate in the study;
• •Patients with any laboratory finding or image finding that in the investigator is opinion can´t participate in the clinical trial;
• •Patients with history of hypersensitivity to any of the formula compounds;
• •Participation in clinical trial in the year prior to this study;
• •Pregnancy or risk of pregnancy and lactating patients;
• •Patients who were in use of drugs that can interfere with evaluation;
• •Decongestants dependent patients or patients receiving allergen specific immunotherapy;
• •Patients on treatment with monoamine oxidase inhibitors (MAOIs).